MatriStem® Wound Products Now Accessible by More Than 100,000 Providers
Columbia, MD – (April 10, 2015) – ACell, Inc. today announced that it has entered into a national group purchasing agreement with Premier, Inc. to offer the Company’s line of MatriStem wound management devices to Premier alliance members.
MatriStem wound devices are the first xenograft products in Premier’s new Regenerative Skin Grafts category, which was created to address the growing demand for regenerative medicine therapies.
Premier, a leading healthcare improvement company, unites an alliance of approximately 3,400 U.S. hospitals and 110,000 other provider members. ACell was awarded a sole-source Premier Regenerative Skin Grafts contract for its MatriStem wound devices. The contract followed a comprehensive review, during which, Premier found that MatriStem wound products demonstrate a benefit to patient care when compared to other available wound products in the regenerative medicine space.
“We look forward to a promising partnership with Premier,” said James A. D’Orta, MD, ACell CEO. “This agreement will bring MatriStem wound devices to a wider healthcare customer base, offering significant financial value to Premier members. Broader access to MatriStem wound devices also gives physicians and their patients an effective choice for complex wound management.
The contract covers all of ACell’s Advanced Wound Care products including MatriStem MicroMatrix®, MatriStem Wound Matrix and MatriStem Burn Matrix devices.
About ACell, Inc.
ACell, Inc. is a leading regenerative medicine company focused on the development, manufacturing and commercialization of unique proprietary extracellular matrix (ECM) products to facilitate the repair and remodeling of damaged tissues. ACell is committed to becoming and remaining an innovative leader in regenerative medical technology, offering superior healing options for doctors and patients. ACell is a privately held company and operates manufacturing facilities in Columbia, MD and Lafayette, IN. For more information, call 800-826-2926 or visit www.acell.com.
About Premier, Inc.
Premier, Inc. is a leading healthcare improvement company, uniting an alliance of approximately 3,400 U.S. hospitals and 110,000 other providers to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and advisory and other services, Premier enables better care and outcomes at a lower cost. Premier, a Malcolm Baldrige National Quality Award recipient, plays a critical role in the rapidly evolving healthcare industry, collaborating with members to co-develop long-term innovations that reinvent and improve the way care is delivered to patients nationwide. Headquartered in Charlotte, N.C., Premier is passionate about transforming American healthcare. Please visit www.premierinc.com.
MatriStem products contain the epithelial basement membrane from porcine urinary bladder, and are based on the proprietary ECM composition generally referred to in scientific literature as urinary bladder matrix, or UBM. UBM is a segment of tissue layers that facilitates a constructive tissue remodeling response by the patient’s body. MatriStem products are indicated for use in general surgery, gynecological surgery, and in the management of a wide range of wounds. Refer to the IFU supplied with each product for indications, contraindications and precautions. All MatriStem products are made in the USA.Return to News